DR. WAQO DULACHA EJERSA: THE QUIET TRANSFORMER DRIVING A NEW ERA AT KEMSA
As Kenya intensifies its fight against cancer, one name continues to stand out in the transformation of the country's health supply chain — *Dr. Waqo Dulacha Ejersa, the Chief Executive Officer of the Kenya Medical Supplies Authority (KEMSA).*
At the official opening of the 9th Kenya International Cancer Conference in Mombasa County today, presided over by Health Cabinet Secretary Hon. Aden Duale, the reforms at KEMSA took centre stage as a key pillar in Kenya's push for equity, excellence and sustainable impact in cancer care.
And behind those reforms is Dr. Ejersa — a leader who is quietly but firmly rebuilding KEMSA into a modern, efficient, transparent and trusted institution.
*From Crisis to Confidence*
When Dr. Ejersa took over at KEMSA, the Authority faced a crisis of confidence — delayed supplies, low fill rates, and questions over accountability.
Today, the story has changed.
Reforms driven under his leadership have pushed *order fill rates to above 90 per cent for most products* — a milestone that means hospitals and health facilities across the country are now receiving the medicines and medical supplies they need, on time.
For a cancer patient in Garissa, Kisumu, Mombasa or Nairobi, that means treatment is no longer delayed because drugs are missing. For a mother, a father, a son or a daughter battling cancer, that means hope.
*Making Cancer Medicines Affordable*
Perhaps the most powerful transformation under Dr. Ejersa has been in making life-saving cancer medicines affordable for ordinary Kenyans.
Through strategic partnerships championed by KEMSA:
- *Partnership with Pfizer* has reduced the prices of *nine innovative cancer medicines by between 70 and 90 per cent.*
- *Collaboration with Roche* has lowered the cost of *Herceptin for eligible breast cancer patients under SHA from KSh 120,000 to KSh 40,000 per session.*
These are not just numbers. These are lives saved. These are families spared from selling land, from harambees, from financial ruin, just to afford treatment.
*Supporting UHC and SHA*
Dr. Ejersa's reforms at KEMSA are directly supporting the Government's Universal Health Coverage agenda.
With 35,867 new cancer cases and 22,888 related deaths reported annually in Kenya, and with 53,465 patients already accessing cancer treatment through the Social Health Authority (SHA), a reliable supply chain is no longer a luxury — it is a matter of life and death.
KEMSA under Dr. Ejersa is now delivering on that mandate.
*Transparency, Accountability, Digital Systems*
Under his leadership, KEMSA has embraced transparency, efficiency and accountability — aligning with the Government's move to implement the National Cancer Control Protocol digitally through the Digital Health Agency and the SHA Oncology Module.
The focus is clear: the right medicine, to the right facility, at the right time, at the right price, with full accountability.
*A Leader With a Vision*
Health stakeholders attending the Mombasa conference, convened by the Kenya Society of Haematology and Oncology (KESHO) under the theme "Equity, Excellence and Sustainable Impact in Cancer Care," say Dr. Ejersa's leadership has restored confidence among development partners, counties, and health facilities.
"He is not loud, but his results are loud," one health official said. "KEMSA is working again."
As Kenya builds six comprehensive cancer care centres across the country, expands oncology programmes to at least 13 counties, and rolls out a funded National Cancer Screening Programme, KEMSA remains the backbone of that ambition.
And at the helm of that backbone is Dr. Waqo Dulacha Ejersa — driving transformation, restoring trust, and ensuring that no Kenyan misses treatment because medicine did not arrive.
Hongera sana, Dr. Ejersa. Hongera KEMSA. The work continues.

Post a Comment